All Sauce from Weekly Sauce:

The U.S. National Institutes of Health could get a new leader in Dr. Monica Bertagnolli, the Boston cancer surgeon who’s led the U.S. National Cancer Institute (NCI) since last fall. On Monday President Joe Biden formally nominated Bertagnolli to the post, which has been filled by an interim director since December 2021, the Washington Post…  read on >  read on >

MONDAY, May 15, 2023 — Researchers have discovered a genetic mutation that should actively protect people from Alzheimer’s, thanks to a man belonging to a Colombian family known to be susceptible to the degenerative brain disease. Based on his family’s genetics, this unnamed patient should have started showing signs of Alzheimer’s in his 40s. “They…  read on >  read on >

Lightbulb inventor Thomas Edison believed a little shuteye could boost his creativity. Contemporary scientists think the iconic innovator was on to something. But timing is key, they say. “We found a strong effect of ‘sleep onset’ on creativity,” said study author Kathleen Esfahany, an undergraduate student focusing on computer science and neuroscience at MIT. Sleep…  read on >  read on >

While the official COVID-19 public health emergency has ended, the virus hasn’t disappeared. Some of the special programs put in place during the pandemic have ended, however, and the University of Michigan offers a guide to help Americans understand what’s changed and what hasn’t. Get vaccinated What hasn’t changed is that the virus continues to…  read on >  read on >

It’s important to understand your bone health to avoid damage as you age. Losses of bone mineral density and bone mass can cause weakening, potentially leading to a fracture, especially in the hip, spine and wrist. Osteoporosis is considered a silent disease because it often has no symptoms until someone breaks a bone in an…  read on >  read on >

It’s important to ask questions when your doctor or dentist writes you a new prescription. This is especially true for opioid pain medications, such as hydrocodone, oxycodone or morphine. While these drugs are approved by the U.S. Food and Drug Administration for acute and chronic pain, they can have serious side effects, including addiction and…  read on >  read on >

The U.S. Food and Drug Administration on Friday approved the first nonhormonal medication aimed at easing menopause hot flashes. The new pill, called Veozah (fezolinetant), is from a class of drugs called neurokinin 3 (NK3) receptor antagonists. It targets a specific brain neuron that’s thought to be set off balance as estrogen levels naturally decline…  read on >  read on >